Allen Bowling, MD, PhD and J. Glen House, MD

Reference

There has been a tremendous amount of research undertaken on multiple sclerosis, beginning in the 19th century. Many of the most important research studies are cited here.

Prevention and Management of Secondary Conditions

Multiple sclerosis (MS) presents a wide array of symptoms that vary by individual. Nineteen specific secondary conditions are addressed, along with treatment and prevention.

Treatment

Multiple sclerosis (MS) is treated primarily with six different drugs, as well as oral and injectable steroids, the result of intense research in disease-modifying medications over the past 15 years.

Diagnosis

Multiple sclerosis (MS) is often first noticed when decreased sensation and visual difficulties appear and disappear over time, usually when a person is in their twenties or thirties.

MS Therapy Advances on the Horizon

"Multiple sclerosis (MS) research is focused on monoclonal antibodies (usually identifiable because the drug name ends with ""mab""). This new breed of drugs uses the body's defense system to fight the disease."

MS Treatment: Advances in MS Therapy

The latest in research for multiple sclerosis (MS) treatment involves switching drug regimens, doubling up on different drugs, comparing Cotapaxone with interferon, drug adherence, and more.

New Warnings About an Old Drug

Could common MS drug modafinil (Provigil) be responsible for severe rashes, allergic reactions, and psychiatric side effects that have been reported? A new study looks at the question.

Osteoporosis and Other "Hidden Diseases" in MS: Part One

Multiple sclerosis (MS) is often linked with osteoporosis as a secondary condition. Make sure that you're checked for this bone-thinning disease.

Osteoporosis and Other "Hidden Diseases" in MS: Part Two

When you have multiple sclerosis (MS), it's important to look for vitamin B12 deficiency, thyroid disease, spinal disease, and other rare conditions that are associated with multiple sclerosis.

Voodoo Death, Placebos, and Optimal Health

Placebo and nocebo responses are marked in trials of multiple sclerosis (MS) drugs, indicating the importance of a positive outlook for MS patients.